Free Trial

Govt Approaches Aspen for Vaccines; Economists Warn of Risks to 1Q21 GDP

SOUTH AFRICA
  • LOCAL NEWS
  • Aspen is part of the J&J vaccine production & 300m doses will be produced in SA for global distribution.
  • J&J promised 50% will go to EM, but trial still in stage 3 & yet to be rolled out -TimesLive
  • Capital Economics warns extended lockdown past 15 Jan could shave more than 0.5% off 2021 GDP (3.5% exp) and the recent outbreak will hamper 1Q21's GDP print and may end in a contraction.
  • Shift from level 1 to 3 closed 20% of the economy & impact will depend on duration of the measures.
  • Local analyst says extension will force manufacturers to take a longer break - DailyMaverick
MNI London Bureau | +44 020-3983-7894 | murray.nichol@marketnews.com
MNI London Bureau | +44 020-3983-7894 | murray.nichol@marketnews.com

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.